Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Patient Addressograph DATE NAME LAST FIRST ID # MIDDLE HOSPITAL OF DELIVERY NEWBORN’S PHYSICIAN REFERRED BY FINAL EDD PRIMARY PROVIDER/GROUP BIRTH DATE AGE RACE ADDRESS MARITAL STATUS S M W D SEP MONTH DAY YEAR OCCUPATION EDUCATION (LAST GRADE COMPLETED) ZIP LANGUAGE PHONE (H) INSURANCE CARRIER/MEDICAID # HUSBAND/DOMESTIC PARTNER PHONE POLICY # FATHER OF BABY PHONE EMERGENCY CONTACT TOTAL PREG FULL TERM PREMATURE AB, INDUCED AB, SPONTANEOUS PHONE E L ECTOPICS MENSTRUAL HISTORY LMP ■ ■ ■ DEFINITE UNKNOWN ■ APPROXIMATE (MONTH KNOWN) ■ NORMAL AMOUNT/DURATION MENSES MONTHLY ■ YES ■ PRIOR MENSES _________ DATE NO FREQUENCY: Q _________ DAYS ON BCP AT CONCEPT ■ YES GA WEEKS LENGTH OF LABOR BIRTH WEIGHT SEX M/F P M TYPE DELIVERY ANES. PRETERM LABOR YES/NO 2. HYPERTENSION 3. HEART DISEASE NO hCG + _____/_____/_____ COMMENTS/ COMPLICATIONS MEDICAL HISTORY ● Neg. + Pos. DETAIL POSITIVE REMARKS INCLUDE DATE & TREATMENT 1. DIABETES LIVING DETAIL POSITIVE REMARKS INCLUDE DATE & TREATMENT 17. D (Rh) SENSITIZED 18. PULMONARY (TB, ASTHMA) 19. SEASONAL ALLERGIES 20. DRUG/LATEX ALLERGIES/ REACTIONS 4. AUTOIMMUNE DISORDER ACOG ANTEPARTUM RECORD (FORM A) A S ● Neg. + Pos. PLACE OF DELIVERY MULTIPLE BIRTHS MENARCHE _______________ (AGE ONSET) ■ FINAL ________ PAST PREGNANCIES (LAST SIX) DATE MONTH/ YEAR (O) 5. KIDNEY DISEASE/UTI 6. NEUROLOGIC/EPILEPSY 21. BREAST 7. PSYCHIATRIC 22. GYN SURGERY 8. DEPRESSION/POSTPARTUM DEPRESSION 23. OPERATIONS/ HOSPITALIZATIONS (YEAR & REASON) 9. HEPATITIS/LIVER DISEASE 10. VARICOSITIES/PHLEBITIS 11. THYROID DYSFUNCTION 24. ANESTHETIC COMPLICATIONS 12. TRAUMA/VIOLENCE 25. HISTORY OF ABNORMAL PAP 13. HISTORY OF BLOOD TRANSFUS. 26. UTERINE ANOMALY/DES AMT/DAY PREPREG 14. TOBACCO AMT/DAY PREG # YEARS USE 27. INFERTILITY 28. RELEVANT FAMILY HISTORY 15. ALCOHOL 16. ILLICIT/RECREATIONAL DRUGS 29. OTHER COMMENTS Version 5. Copyright © 2003 The American College of Obstetricians and Gynecologists, 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920 AA128 12345/76543 Patient Addressograph SYMPTOMS SINCE LMP GENETIC SCREENING/TERATOLOGY COUNSELING E L INCLUDES PATIENT, BABY'S FATHER, OR ANYONE IN EITHER FAMILY WITH: YES NO 1. PATIENT'S AGE ≥ 35 YEARS AS OF ESTIMATED DATE OF DELIVERY 12. HUNTINGTON’S CHOREA 2. THALASSEMIA (ITALIAN, GREEK, MEDITERRANEAN, OR ASIAN BACKGROUND): MCV <80 13. MENTAL RETARDATION/AUTISM YES NO YES NO IF YES, WAS PERSON TESTED FOR FRAGILE X? 3. NEURAL TUBE DEFECT (MENINGOMYELOCELE, SPINA BIFIDA, OR ANENCEPHALY) 14. OTHER INHERITED GENETIC OR CHROMOSOMAL DISORDER 4. CONGENITAL HEART DEFECT 15. MATERNAL METABOLIC DISORDER (EG, TYPE 1 DIABETES, PKU) P M 16. PATIENT OR BABY'S FATHER HAD A CHILD WITH BIRTH DEFECTS NOT LISTED ABOVE 5. DOWN SYNDROME 6. TAY–SACHS (EG, JEWISH, CAJUN, FRENCH CANADIAN) 17. RECURRENT PREGNANCY LOSS, OR A STILLBIRTH 7. CANAVAN DISEASE 18. MEDICATIONS (INCLUDING SUPPLEMENTS, VITAMINS, HERBS OR OTC DRUGS)/ILLICIT/RECREATIONAL DRUGS/ALCOHOL SINCE LAST MENSTRUAL PERIOD 8. SICKLE CELL DISEASE OR TRAIT (AFRICAN) 9. HEMOPHILIA OR OTHER BLOOD DISORDERS IF YES, AGENT(S) AND STRENGTH/DOSAGE 10. MUSCULAR DYSTROPHY 19. ANY OTHER 11. CYSTIC FIBROSIS A S COMMENTS/COUNSELING INFECTION HISTORY 1. LIVE WITH SOMEONE WITH TB OR EXPOSED TO TB 2. PATIENT OR PARTNER HAS HISTORY OF GENITAL HERPES YES NO 4. HISTORY OF STD, GONORRHEA, CHLAMYDIA, HPV, SYPHILIS 5. OTHER (See Comments) 3. RASH OR VIRAL ILLNESS SINCE LAST MENSTRUAL PERIOD COMMENTS INTERVIEWER’S SIGNATURE DATE ________ / ________ / ________ HEIGHT ___________ BP__________ 1. HEENT ■ NORMAL ■ ABNORMAL 12. VULVA ■ NORMAL ■ CONDYLOMA ■ LESIONS 2. FUNDI ■ NORMAL ■ ABNORMAL 13. VAGINA ■ NORMAL ■ INFLAMMATION ■ DISCHARGE 3. TEETH ■ NORMAL ■ ABNORMAL 14. CERVIX ■ NORMAL ■ INFLAMMATION ■ LESIONS 4. THYROID ■ NORMAL ■ ABNORMAL 15. UTERUS SIZE __________ WEEKS ■ FIBROIDS 5. BREASTS ■ NORMAL ■ ABNORMAL 16. ADNEXA ■ NORMAL ■ MASS 6. LUNGS ■ NORMAL ■ ABNORMAL 17. RECTUM ■ NORMAL ■ ABNORMAL 7. HEART ■ NORMAL ■ ABNORMAL 18. DIAGONAL CONJUGATE ■ REACHED ■ NO __________ CM 8. ABDOMEN ■ NORMAL ■ ABNORMAL 19. SPINES ■ AVERAGE ■ PROMINENT ■ BLUNT 9. EXTREMITIES ■ NORMAL ■ ABNORMAL 20. SACRUM ■ CONCAVE ■ STRAIGHT ■ ANTERIOR 10. SKIN ■ NORMAL ■ ABNORMAL 21. SUBPUBIC ARCH ■ NORMAL ■ WIDE ■ NARROW 11. LYMPH NODES ■ NORMAL ■ ABNORMAL 22. GYNECOID PELVIC TYPE ■ YES ■ NO COMMENTS (Number and explain abnormals) EXAM BY ACOG ANTEPARTUM RECORD (FORM B) INITIAL PHYSICAL EXAMINATION Patient Addressograph NAME LAST FIRST DRUG ALLERGY MIDDLE LATEX ALLERGY IS BLOOD TRANSFUSION ACCEPTABLE IN AN EMERGENCY? ■ YES ■ NO ■ YES ANESTHESIA CONSULT PLANNED ■ NO PROBLEMS/PLANS MEDICATION LIST Start date 1. 1. ______ / ______ / ______ ______ / ______ / ______ 2. 2. ______ / ______ / ______ ______ / ______ / ______ 3. 3. ______ / ______ / ______ ______ / ______ / ______ 4. 4. ______ / ______ / ______ ______ / ______ / ______ 5. 5. ______ / ______ / ______ ______ / ______ / ______ 6. 6. ______ / ______ / ______ ______ / ______ / ______ 18–20-WEEK EDD UPDATE INITIAL EDD LMP ______ / ______ / ______ E L P M EDD CONFIRMATION Stop date = EDD ______ / ______ / ______ QUICKENING _______ / _______ / _______ +22 WKS = _______ / _______ / _______ _______ / _______ / _______ +20 WKS = _______ / _______ / _______ ______ / ______ / ______ = ______ WKS = EDD ______ / ______ / ______ ULTRASOUND ______ / ______ / ______ = ______ WKS = EDD ______ / ______ / ______ ULTRASOUND _______ / _______ / _______ = _______ WKS = _______ / _______ / _______ INITIAL EDD ______ / ______ / ______ FINAL EDD _______ / _______ / _______ COMMENTS (A LB UM NE IN /G XT LU AP CO PO SE IN ) TM PR EN O VI T DE R (IN IT IA LS ) FE TA L FU N D AL W EE KS PROBLEMS COMMENTS ACOG ANTEPARTUM RECORD (FORM C) A S INITIALED BY __________________________ UR IN E INITIALED BY _______________________ M O VE PR M ET EN SI E T G RM N += S L PR /SY AB ES MP OR EN TO CE T M RV ● =A S: UL IX TR E BS AS XA EN O M T UN (D I D L. BL LE /EF O O NG F. D TH STA PR .) ES S W UR EI E G HT G ES T. _______________ H EI G H T (B ES T ES T.) PREPREGNANCY WEIGHT PR ES (C EN M ) TA TI O N FH R INITIAL EXAM FUNDAL HT. AT UMBIL. Patient Addressograph LABORATORY AND EDUCATION INITIAL LABS DATE RESULT BLOOD TYPE / / D (Rh) TYPE / / ANTIBODY SCREEN / / HCT/HGB / / __________ % _________ g/dL PAP TEST / / NORMAL/ABNORMAL/________ RUBELLA / / VDRL / / URINE CULTURE/SCREEN / / HBsAg / / HIV COUNSELING/TESTING* / / OPTIONAL LABS / PPD / / CHLAMYDIA / / GONORRHEA / / GENETIC SCREENING TESTS (SEE FORM B) / / O DATE NEG. DECLINED AA AS SS AC SC AF ↓ A2 RESULT ULTRASOUND / / MSAFP/MULTIPLE MARKERS / / AMNIO/CVS / / KARYOTYPE / / 46,XX OR 46,XY/OTHER_______ AMNIOTIC FLUID (AFP) / / NORMAL_____ ABNORMAL_____ 24–28-WEEK LABS (WHEN INDICATED) DATE RESULT / / __________ % _________ g/dL DIABETES SCREEN / / 1 HOUR______________________ GTT (IF SCREEN ABNORMAL) / / ______FBS ______1 HOUR ______2 HOUR ______3 HOUR / / ANTI-D IMMUNE GLOBULIN (RhlG) GIVEN (28 WKS) / / SIGNATURE ________________________________ 32–36-WEEK LABS DATE RESULT HCT/HGB / / ULTRASOUND (WHEN INDICATED) / / VDRL (WHEN INDICATED) / / GONORRHEA (WHEN INDICATED) / / CHLAMYDIA (WHEN INDICATED) / / GROUP B STREP / / *Check state requirements before recording results. PROVIDER SIGNATURE (AS REQUIRED) __________ % _________ g/dL ACOG ANTEPARTUM RECORD (FORM D) HCT/HGB D (Rh) ANTIBODY SCREEN E L P M POS. A S (WHEN INDICATED/ AB RESULT / 8–18-WEEK LABS ELECTED) B COMMENTS/ADDITIONAL LABS DATE HGB ELECTROPHORESIS OTHER A REVIEWED Patient Addressograph NAME LAST PLANS/EDUCATION (COUNSELED ■ )—BY TRIMESTER. FIRST MIDDLE INITIAL AND DATE WHEN DISCUSSED. FIRST TRIMESTER ■ HIV AND OTHER ROUTINE PRENATAL TESTS ■ RISK FACTORS IDENTIFIED BY PRENATAL HISTORY ■ ANTICIPATED COURSE OF PRENATAL CARE ■ NUTRITION AND WEIGHT GAIN COUNSELING ■ TOXOPLASMOSIS PRECAUTIONS (CATS/RAW MEAT) ■ SEXUAL ACTIVITY ■ EXERCISE ■ ENVIRONMENTAL/WORK HAZARDS ■ TRAVEL ■ TOBACCO (ASK, ADVISE, ASSESS, ASSIST, AND ARRANGE) ■ ALCOHOL ■ ILLICIT/RECREATIONAL DRUGS ■ USE OF ANY MEDICATIONS (INCLUDING SUPPLEMENTS, VITAMINS, HERBS, OR OTC DRUGS) ■ INDICATIONS FOR ULTRASOUND ■ DOMESTIC VIOLENCE ■ SEAT BELT USE ■ CHILDBIRTH CLASSES/HOSPITAL FACILITIES SIGNS AND SYMPTOMS OF PRETERM LABOR ■ ABNORMAL LAB VALUES ■ INFLUENZA VACCINE ■ SELECTING A PEDIATRICIAN ■ POSTPARTUM FAMILY PLANNING/TUBAL STERILIZATION E L P M SECOND TRIMESTER ■ NEED FOR FURTHER DISCUSSION COMPLETED ■ ANESTHESIA/ANALGESIA PLANS ■ FETAL MOVEMENT MONITORING ■ LABOR SIGNS ■ VBAC COUNSELING ■ SIGNS AND SYMPTOMS OF PREGNANCY-INDUCED HYPERTENSION ■ POSTTERM COUNSELING ■ CIRCUMCISION ■ BREAST OR BOTTLE FEEDING ■ POSTPARTUM DEPRESSION ■ NEWBORN CAR SEAT ■ FAMILY MEDICAL LEAVE OR DISABILITY FORMS ACOG ANTEPARTUM RECORD (FORM E) A S THIRD TRIMESTER REQUESTS TUBAL STERILIZATION CONSENT SIGNED HISTORY AND PHYSICAL HAS BEEN SENT TO HOSPITAL, IF APPLICABLE. DATE INITIALS ____/____/____ ____________ DATE INITIALS ____/____/____ ____________ Version 5. Copyright © 2002 The American College of Obstetricians and Gynecologists, 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920 AA128 12345/76543 Patient Addressograph Plans/Education Notes E L ACOG ANTEPARTUM RECORD (FORM E, continued) A S P M Patient Addressograph NAME LAST FIRST MIDDLE ID # EDD (A LB UM NE IN /G XT LU AP CO PO SE IN ) TM PR EN O VI T DE R (IN IT IA LS ) E L UR IN E M O VE PR M ET EN SI E T G RM N += S L PR /SY AB ES MP OR EN TO CE T M RV ● =A S: UL IX TR E BS AS XA EN O M T UN (D I D L. BL LE /EF O O NG F. D TH STA PR .) ES S W UR EI E G HT FU N D AL W EE KS G ES T. _______________ FE TA L (B ES T PREPREGNANCY WEIGHT ES H T.) EI G H PR T ES (C EN M ) TA TI O N FH R Supplemental Visits COMMENTS P M Progress Notes ACOG ANTEPARTUM RECORD (FORM F) A S PROVIDER SIGNATURE (AS REQUIRED) Version 5. Copyright © 2002 The American College of Obstetricians and Gynecologists, 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920 AA128 12345/76543 G ES T. PREPREGNANCY WEIGHT A S Progress Notes (A LB UM NE IN /G XT LU AP CO PO SE IN ) TM PR EN O VI T DE R (IN IT IA LS ) UR IN E FIRST P M ACOG ANTEPARTUM RECORD (FORM F, continued) PROVIDER SIGNATURE (AS REQUIRED) M O VE PR M ET EN SI E T G RM N += S L PR /SY AB ES MP OR EN TO CE T M RV ● =A S: UL IX TR E BS AS XA EN O M T UN (D I D L. BL LE /EF O O NG F. D TH STA PR .) ES S W UR EI E G HT LAST FE TA L ES H T.) EI G H PR T ES (C EN M ) TA TI O N FH R (B ES T _______________ FU N D AL W EE KS Patient Addressograph NAME MIDDLE ID # EDD visits Supplemental Visits COMMENTS E L Patient Addressograph NAME LAST FIRST MIDDLE ID # Progress Notes E L P M ACOG ANTEPARTUM RECORD (FORM G) A S PROVIDER SIGNATURE (AS REQUIRED) Version 5. Copyright © 2002 The American College of Obstetricians and Gynecologists, 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920 AA128 12345/76543 Patient Addressograph NAME LAST FIRST MIDDLE ID # Progress Notes E L P M PROVIDER SIGNATURE (AS REQUIRED) ACOG ANTEPARTUM RECORD (FORM G, continued) A S